US EditionPublished • loading... • Updated
Als Expected to Be Controlled with a Compound; Pharmaceutical Companies Sought to Participate in Clinical Trials in Nara (Kyodo News)
Summary by 熊本日日新聞社
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
A team from Nara Medical University, Tokushima University, and other institutions announced on the 28th that they have discovered a compound that controls a substance believed to be the cause of amyotrophic lateral sclerosis (ALS), a nationally designated intractable disease that gradually impairs the body's ability to move. This discovery could potentially lead to a fundamental cure, and the team is working with a venture company spun off from …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
